We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Apotex Surrenders In Plavix Patent Saga

Law360 (March 22, 2006, 12:00 AM EST) -- Hoisting up its white flag, Canadian drug maker Apotex Inc. has snatched up a settlement offered by French pharmaceutical giant Sanofi-Aventis and U.S. partner Bristol-Myers Squibb, potentially ending one battle in the epic war over blockbuster blood thinner Plavix.

Sanofi and Bristol-Myers revealed the news on Tuesday, noting that they had also approached Dr. Reddy’s Laboratories with a similar arrangement.

Co-marketed with Bristol-Myers Squibb, Plavix is Sanofi-Aventis's ground-breaking stroke medication.

Since 2002, Apotex and India-based Dr. Reddy’s have been seeking to strip Sanofi of the Plavix...
To view the full article, register now.